Evidence map›Paper›PMID 37899696›Full record

ArticleClinical and translational science2023

Free heme and hemopexin in acute kidney injury after cardiopulmonary bypass and transient renal ischemia.

Robert Greite, Sebastian Schott, Li Wang, Lukas Gohlke, Kirill Kreimann, Katja Derlin, Marcel Gutberlet, Martina Schmidbauer, Andreas Leffler, Igor Tudorache and 18 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Research progress on biomarkers for acute kidney injury in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 3 institutions in 3 countries.

Robert GreiteDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Sebastian SchottDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Li WangDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Lukas GohlkeDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Kirill KreimannDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Katja DerlinInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Marcel GutberletInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Martina SchmidbauerInstitute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Andreas LefflerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Igor TudoracheDepartment of Cardiac Surgery, University Hospital Dusseldorf, Dusseldorf, Germany.
Jawad SalmanDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Fabio IusDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Ruslan NatanovDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Christine FegbeutelDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Axel HaverichDepartment of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Ralf LichtinghagenDepartment of Clinical Chemistry, Hannover Medical School, Hannover, Germany.
Anne M HüsingDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Sibylle von VietinghoffDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Roland SchmittDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Nelli ShushakovaDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Song RongDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Hermann HallerDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Kai M Schmidt-OttDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Magnus GramPediatrics, Department of Clinical Sciences Lund, Skane University Hospital, Lund University, Lund, Sweden.
Vijith VijayanInstitute for Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
Irina ScheffnerDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Wilfried GwinnerDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Stephan ImmenschuhInstitute for Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEDüsseldorf University Hospital · DELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free heme is released from hemoproteins during hemolysis or ischemia reperfusion injury and can be pro-inflammatory. Most studies on nephrotoxicity of hemolysis-derived proteins focus on free hemoglobin (fHb) with heme as a prosthetic group. Measurement of heme in its free, non-protein bound, form is challenging and not commonly used in clinical routine diagnostics. In contrast to fHb, the role of free heme in acute kidney injury (AKI) after cardiopulmonary bypass (CPB) surgery is unknown. Using an apo-horseradish peroxidase-based assay, we identified free heme during CPB surgery as predictor of AKI in patients undergoing cardiac valve replacement (n = 37). Free heme levels during CPB surgery correlated with depletion of hemopexin (Hx), a heme scavenger-protein. In mice, the impact of high levels of circulating free heme on the development of AKI following transient renal ischemia and the therapeutic potential of Hx were investigated. C57BL/6 mice were subjected to bilateral renal ischemia/reperfusion injury for 15 min which did not cause AKI. However, additional administration of free heme in this model promoted overt AKI with reduced renal function, increased renal inflammation, and reduced renal perfusion on functional magnetic resonance imaging. Hx treatment attenuated AKI. Free heme administration to sham operated control mice did not cause AKI. In conclusion, free heme is a predictor of AKI in CPB surgery patients and promotes AKI in transient renal ischemia. Depletion of Hx in CPB surgery patients and attenuation of AKI by Hx in the in vivo model encourage further research on Hx therapy in patients with increased free heme levels during CPB surgery.

Indexed as

Acute Kidney InjuryHemopexinReperfusion InjuryAnimalsCardiopulmonary BypassHemeHemoglobinsHemolysisHumansIschemiaKidneyMiceMice, Inbred C57BLHemeHemoglobinsHemopexin

Identifiers

PMID37899696
PMCPMC10719480
OpenAlexW4388013880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.